A central feature of RA is the presence of autoantibodies, notably anti-citrullinated peptide antibodies (ACPA), which exhibit high specificity for the disease and serve as important diagnostic and prognostic markers (3, 4). This evidence concerns the gene PRTN3 and rheumatoid arthritis.